Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents [note 4] $ 10,581 $ 34,310
Short-term investments [note 4] 29,147 20,876
Interest receivable 47 111
Prepaid expenses 1,298 1,987
Other current assets 307 14
Total current assets 41,380 57,298
Restricted cash [note 4 and note 7] 272 272
Property and equipment, net 534 602
Other assets 12 37
Total assets 42,198 58,209
Current liabilities:    
Accounts payable 559 1,343
Accrued liabilities other 622 641
Accrued clinical liabilities 7,703 9,966
Accrued compensation 1,328 1,267
Accrued litigation settlement liability [note 3, note 7 and note 8] 1,375  
Current portion of long-term obligations [note 7] 57 52
Lease termination liability [note 7] 1,250 1,250
Deferred collaboration revenue [note 3]   5,040
Warrant liability [note 4 and note 5] 971 1,105
Total current liabilities 13,865 20,664
Long-term obligations, less current portion [note 7] 84 105
Total liabilities 13,949 20,769
Commitments and contingencies [note 7]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 30,043,723 and 29,846,991 issued at June 30, 2016 and December 31, 2015, respectively, and 30,009,730 and 29,812,998 outstanding at June 30, 2016 and December 31, 2015, respectively 29 29
Additional paid-in capital 212,977 211,590
Accumulated deficit (187,407) (176,811)
Accumulated other comprehensive income 2,650 2,632
Total stockholders' equity 28,249 37,440
Total liabilities and stockholders' equity $ 42,198 $ 58,209